A new blood test for Alzheimer's disease has been developed under the leadership of researchers at the University of Gothenburg. The method is based on measuring a specific variant of tau protein in ordinary blood samples, ...
Apr 23, 2020
0
29
Neurodegenerative diseases affect millions of people worldwide and as our life expectancy increases, more individuals are expected to be affected in the coming decades. Tauopathies such as Alzheimer's disease are a class ...
Jan 6, 2023
0
87
A new Northwestern Medicine study showed cognitive SuperAgers have resistance to the development of fibrous tangles in a brain region related to memory and which are known to be markers of Alzheimer's disease.
Feb 17, 2021
0
19
The largest analysis to date of genetic data in amyotrophic lateral sclerosis (ALS) - the muscle-crippling neurodegenerative disease that afflicted the late astrophysicist Stephen Hawking and cut short the career of iconic ...
Apr 9, 2018
0
173
In November, researchers reported the drug lecanemab slowed the progression of Alzheimer's disease. The effect was modest, but it has generated tremendous excitement because it was the first time a drug had been shown to ...
Dec 27, 2022
0
107
We have known for some years that Alzheimer's disease is characterised by two types of lesions, amyloid plaques and degenerated tau protein. Cholesterol plays an important role in the physiopathology of this disease. Two ...
Sep 14, 2015
0
30
An experimental drug can reduce the toxic changes in tau proteins known to damage neurons in brains with Alzheimer's disease, researchers from Yale School of Medicine and Johns Hopkins University report.
Nov 6, 2023
0
83
In the years since her lab discovered that exposing Alzheimer's disease model mice to light flickering at the frequency of a key brain rhythm could stem the disorder's pathology, MIT neuroscientist Li-Huei Tsai and her team ...
Oct 22, 2019
0
63
Dementia is defined as the loss of cognitive functioning—including thinking, remembering, and reasoning—and is very prevalent in Japan. Currently, the treatment satisfaction for dementia is among the lowest and no drug ...
May 29, 2023
0
52
A new Sanford Burnham Prebys Medical Discovery Institute (SBP) study takes a step forward in understanding how similar, yet genetically unrelated neurodegenerative diseases, such as Alzheimer's disease, frontal temporal dementia, ...
Sep 2, 2015
0
89
